Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Diseases of the Colon & Rectum
Published in: Diseases of the Colon & Rectum 1/2007

01-01-2007

Differences in Yeast Intolerance Between Patients with Crohn’s Disease and Ulcerative Colitis

Authors: Brigitt Brunner, M.D., Ulrich Scheurer, M.D., Frank Seibold, M.D.

Published in: Diseases of the Colon & Rectum | Issue 1/2007

Login to get access

Purpose

Alimentary factors, especially those modifying the intestinal flora, may influence the course of inflammatory bowel disease. It is known that T and B cells of patients with Crohn’s disease can be stimulated with the yeast antigen, mannan. We evaluated the impact of eating habits with special respect to food containing yeast on the course of inflammatory bowel disease.

Methods

Questionnaires were sent to 180 German-speaking patients of the Inflammatory Bowel Disease Outpatient Clinic at the University Hospital Bern, Switzerland. The following information was obtained by the questionnaires: (1) course of disease, (2) eating habits, (3) environmental data, and (4) inflammatory bowel disease questionnaire. The survey was anonymous.

Results

A total of 145 patients (80.5 percent 95 with Crohn’s disease, and 50 with ulcerative colitis) responded. Food items containing yeast were better tolerated by patients with ulcerative colitis than by patients with Crohn’s disease. A significant difference between the two groups was observed concerning food containing raw yeast (dough, P = 0.04; and pastry, P = 0.001).

Conclusions

Food items containing raw yeast led to more frequent problems for patients with Crohn’s disease than for patients with ulcerative colitis. This observation supports our previous data, which showed the stimulatory effect of the yeast antigen, mannan, on B and T cells of patients with Crohn’s disease but not of controls.
Literature
1.
Calkins, BM 1989A meta-analysis of the role of smoking in inflammatory bowel diseaseDig Dis Sci3418411854PubMedCrossRef
2.
Sutherland, LR, Ramcharan, S, Bryant, H, Fick, G 1990Effect of cigarette smoking on recurrence of Crohn’s diseaseGastroenterology9811231128PubMed
3.
Sutton, CL, Yang, H, Li, Z, Rotter, JI, Targan, SR, Braun, J 2000Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn’s diseaseGut465863PubMedCrossRef
4.
Vermeire, S, Joossens, S, Peeters, M,  et al. 2001Comparative study of ASCA (anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel diseaseGastroenterology120827833PubMedCrossRef
5.
Seibold, F, Stich, O, Hufnagl, R, Kamil, S, Scheurlen, M 2001Anti-Saccharomyces cerevisiae antibodies in inflammatory bowel disease: a family studyScand J Gastroenterol36196201PubMedCrossRef
6.
Vermeire, S, Peeters, M, Vlictinck, R,  et al. 2001Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD familiesInflamm Bowel Dis7815PubMedCrossRef
7.
Peeters, M, Joossens, S, Vermeire, S, Vlietinck, R, Bossuyt, X, Rutgeerts, P 2001Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseaseAm J Gastroenterol96730734PubMedCrossRef
8.
Annese, V, Andreoli, A, Andriulli, A,  et al. 2001Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in Crohn’s disease and ulcerative colitis: aGISC studyAm J Gastroenterol9624072412PubMedCrossRef
9.
Quinton, JF, Sendid, B, Reumaux, D,  et al. 1998Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic roleGut42788791PubMedCrossRef
10.
Konrad, A, Rutten, C, Flogerzi, B, Styner, M, Goke, B, Seibold, F 2004Immune sensitization to yeast antigens in ASCA-positive patients with Crohn’s diseaseInflamm Bowel Dis1097105PubMedCrossRef
11.
Seibold, F, Konrad, A, Flogerzi, B,  et al. 2004Genetic variants of the mannan-binding lectin are associated with immune reactivity to mannans in Crohn’s diseaseGastroenterology12710761084PubMedCrossRef
12.
13.
Tada, H, Nemoto, E, Shimauchi, H,  et al. 2002Saccharomyces cerevisiae and Candida albicans derived mannan induced production of tumor necrosis factor alpha by human monocytes in a CD 14- and Toll-like receptor 4- dependent mannerMicrobiol Immunol46503512PubMed
14.
Franchimont, D, Vermeire, S, Housni, H,  et al. 2004Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn’s disease and ulcerative colitisGut53987992PubMedCrossRef
15.
Mitchell, A, Guyatt, G, Singer, J,  et al. 1988Quality of life in patients with inflammatory bowel diseaseJ Clin Gastroenterol10306310PubMedCrossRef
16.
Guyatt, G, Mitchell, A, Irvine, EJ,  et al. 1989A new measure of health status for clinical trials in inflammatory bowel diseaseGastroenterology96804810PubMed
17.
Kocourek, J, Ballou, CE 1969Method for fingerprinting yeast cell wall mannansJ Bacteriol10011751181PubMed
18.
Mayberry, JF, Rhodes, J 1984Epidemiological aspects of Crohn’s disease: a review of literatureGut25886899PubMed
19.
Calkins, BM, Medeloff, AI 1986Epidemiology of inflammatory bowel diseaseEpidemiol Rev86091PubMed
20.
Barclay, GR, McKenzie, H, Pennington, J, Parratt, D, Pennington, CR 1992The effect of dietary yeast on the activity of stable chronic Crohn’s diseaseScand J Gastroenterol27196200PubMed
21.
Vasiliauskas, EA, Kam, LY, Karp, LC, Gaiennie, J, Yang, H, Targan, SR 2000Marker antibody expression stratifies Crohn’s disease into immunologically homogenous subgroups with distinct clinical characteristicsGut47487496PubMedCrossRef
22.
Walker, LJ, Aldhous, MC, Drummond, HE,  et al. 2004Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn’s disease are associated with disease severity but not NOD2/CARD15 mutationsClin Exp Immunol135490496PubMedCrossRef
23.
Zholudev, A, Zurakowski, D, Young, W, Leichtner, A, Bousvaros, A 2004Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn’s disease and ulcerative colitis: diagnostic value and correlation with disease phenotypeAm J Gastroenterol9922352241PubMedCrossRef
Metadata
Title
Differences in Yeast Intolerance Between Patients with Crohn’s Disease and Ulcerative Colitis
Authors
Brigitt Brunner, M.D.
Ulrich Scheurer, M.D.
Frank Seibold, M.D.
Publication date
01-01-2007
Publisher
Springer-Verlag
Published in
Diseases of the Colon & Rectum / Issue 1/2007
Print ISSN: 0012-3706
Electronic ISSN: 1530-0358
DOI
https://doi.org/10.1007/s10350-006-0749-1

Other articles of this Issue 1/2007

Diseases of the Colon & Rectum 1/2007 Go to the issue

OriginalPaper

Early Results of Surgery in 123 Patients with Pseudomyxoma Peritonei from a Perforated Appendiceal Neoplasm

Current Status

The Role of Positron Emission Tomography in the Management of Recurrent Colorectal Cancer: A Review

OriginalPaper

Colon and Rectal Surgery Regional Society Meetings

OriginalPaper

Sonographic Characteristics of Rectal Sensations in Healthy Females

OriginalPaper

Risk Factors for Anemia in Patients with Ileal Pouch-Anal Anastomosis

OriginalPaper

Combining Cisplatin and Mitomycin with Radiotherapy in Anal Carcinoma